skip-to-main

COVID‑19 Vaccine Moderna

Emergency Use Authorization (EUA) has been amended for the COVID-19 mRNA Vaccine (now known as Spikevax) in the Philippines to expand the therapeutic indication to 12 years of age and older.

Patient Information Leaflet

Patient Information Leaflet

Summary Product Characteristics

Summary Product Characteristics

U.S. Moderna COVID-19 Vaccine Lots and Expiry Dates and Labelling

U.S. Moderna COVID-19 Vaccine Lots and Expiry Dates and Labelling

Contact Moderna